» Articles » PMID: 35530510

Benefits of Curcumin in the Vasculature: A Therapeutic Candidate for Vascular Remodeling in Arterial Hypertension and Pulmonary Arterial Hypertension?

Overview
Journal Front Physiol
Date 2022 May 9
PMID 35530510
Authors
Affiliations
Soon will be listed here.
Abstract

Growing evidence suggests that hypertension is one of the leading causes of cardiovascular morbidity and mortality since uncontrolled high blood pressure increases the risk of myocardial infarction, aortic dissection, hemorrhagic stroke, and chronic kidney disease. Impaired vascular homeostasis plays a critical role in the development of hypertension-induced vascular remodeling. Abnormal behaviors of vascular cells are not only a pathological hallmark of hypertensive vascular remodeling, but also an important pathological basis for maintaining reduced vascular compliance in hypertension. Targeting vascular remodeling represents a novel therapeutic approach in hypertension and its cardiovascular complications. Phytochemicals are emerging as candidates with therapeutic effects on numerous pathologies, including hypertension. An increasing number of studies have found that curcumin, a polyphenolic compound derived from dietary spice turmeric, holds a broad spectrum of pharmacological actions, such as antiplatelet, anticancer, anti-inflammatory, antioxidant, and antiangiogenic effects. Curcumin has been shown to prevent or treat vascular remodeling in hypertensive rodents by modulating various signaling pathways. In the present review, we attempt to focus on the current findings and molecular mechanisms of curcumin in the treatment of hypertensive vascular remodeling. In particular, adverse and inconsistent effects of curcumin, as well as some favorable pharmacokinetics or pharmacodynamics profiles in arterial hypertension will be discussed. Moreover, the recent progress in the preparation of nano-curcumins and their therapeutic potential in hypertension will be briefly recapped. The future research directions and challenges of curcumin in hypertension-related vascular remodeling are also proposed. It is foreseeable that curcumin is likely to be a therapeutic agent for hypertension and vascular remodeling going forwards.

Citing Articles

Updates in the management of hypertension.

Ramdani S, Haddiya I Ann Med Surg (Lond). 2024; 86(6):3514-3521.

PMID: 38846840 PMC: 11152838. DOI: 10.1097/MS9.0000000000002052.


Enhancing the Bioavailability and Bioactivity of Curcumin for Disease Prevention and Treatment.

Bertoncini-Silva C, Vlad A, Ricciarelli R, Giacomo Fassini P, Suen V, Zingg J Antioxidants (Basel). 2024; 13(3).

PMID: 38539864 PMC: 10967568. DOI: 10.3390/antiox13030331.


Curcumin Nanoemulsion: Unveiling Cardioprotective Effects via ACE Inhibition and Antioxidant Properties in Hypertensive Rats.

Ishaq M, Khan M, Verma G, Rathi A, Adil M, Faizan M Medicina (Kaunas). 2023; 59(10).

PMID: 37893466 PMC: 10608169. DOI: 10.3390/medicina59101748.


Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis.

Phua T Front Aging. 2023; 4:1196648.

PMID: 37384143 PMC: 10293850. DOI: 10.3389/fragi.2023.1196648.


MiR-155-5p Attenuates Vascular Smooth Muscle Cell Oxidative Stress and Migration via Inhibiting BACH1 Expression.

Tong Y, Zhou M, Li S, Zhao H, Zhang Y, Chen D Biomedicines. 2023; 11(6).

PMID: 37371773 PMC: 10295705. DOI: 10.3390/biomedicines11061679.


References
1.
Huo M, Cao X, Zhang H, Lau C, Hong H, Chen F . Loss of myeloid Bmal1 exacerbates hypertensive vascular remodelling through interaction with STAT6 in mice. Cardiovasc Res. 2021; 118(13):2859-2874. DOI: 10.1093/cvr/cvab336. View

2.
Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, Nagasawa A . The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest. 2008; 118(3):868-78. PMC: 2248328. DOI: 10.1172/JCI33160. View

3.
Lu H, Du W, Ren L, Hamblin M, Becker R, Chen Y . Vascular Smooth Muscle Cells in Aortic Aneurysm: From Genetics to Mechanisms. J Am Heart Assoc. 2021; 10(24):e023601. PMC: 9075263. DOI: 10.1161/JAHA.121.023601. View

4.
Li H, Yang M, Li Z, Meng Z . Curcumin inhibits angiotensin II-induced inflammation and proliferation of rat vascular smooth muscle cells by elevating PPAR-γ activity and reducing oxidative stress. Int J Mol Med. 2017; 39(5):1307-1316. DOI: 10.3892/ijmm.2017.2924. View

5.
Wu N, Ye C, Zheng F, Wan G, Wu L, Chen Q . MiR155-5p Inhibits Cell Migration and Oxidative Stress in Vascular Smooth Muscle Cells of Spontaneously Hypertensive Rats. Antioxidants (Basel). 2020; 9(3). PMC: 7140008. DOI: 10.3390/antiox9030204. View